Efficacy - Safety of Eflornithine-Nifurtimox Combination Versus Eflornithine to Treat Human African Trypanosomiasis

NCT00146627 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

280

Enrollment

OTHER

Sponsor class

Conditions

Trypanosomiasis, African

Interventions

DRUG: Eflornithine
DRUG: Nifurtimox

Sponsor

Drugs for Neglected Diseases

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]